<?xml version="1.0" encoding="UTF-8"?>
<edgarSubmission xsi:schemaLocation="http://www.sec.gov/edgar/thirteenffiler eis_13F_Filer.xsd" xmlns:ns1="http://www.sec.gov/edgar/common" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.sec.gov/edgar/thirteenffiler">
  <schemaVersion>X0202</schemaVersion>
  <headerData>
    <submissionType>13F-NT</submissionType>
    <filerInfo>
      <liveTestFlag>LIVE</liveTestFlag>
      <flags/>
      <filer>
        <credentials>
          <cik>0001818893</cik>
          <ccc>XXXXXXXX</ccc>
        </credentials>
      </filer>
      <periodOfReport>09-30-2026</periodOfReport>
    </filerInfo>
  </headerData>
  <formData>
    <coverPage>
      <reportCalendarOrQuarter>09-30-2026</reportCalendarOrQuarter>
      <isAmendment>false</isAmendment>
      <filingManager>
        <name>BCLS II Investco, LP</name>
        <address>
          <ns1:street1>200 CLARENDON STREET</ns1:street1>
          <ns1:city>BOSTON</ns1:city>
          <ns1:stateOrCountry>MA</ns1:stateOrCountry>
          <ns1:zipCode>02116</ns1:zipCode>
        </address>
      </filingManager>
      <reportType>13F NOTICE</reportType>
      <form13FFileNumber>028-22978</form13FFileNumber>
      <otherManagersInfo>
        <otherManager>
          <form13FFileNumber>28-18477</form13FFileNumber>
          <name>Bain Capital Life Sciences Investors, LLC</name>
        </otherManager>
        <otherManager>
          <form13FFileNumber>28-20816</form13FFileNumber>
          <name>Bain Capital Life Sciences Investors II, LLC</name>
        </otherManager>
        <otherManager>
          <form13FFileNumber>28-20814</form13FFileNumber>
          <name>Bain Capital Life Sciences Fund II, L.P.</name>
        </otherManager>
        <otherManager>
          <form13FFileNumber>28-22976</form13FFileNumber>
          <name>BCLS II Investco (GP), LLC</name>
        </otherManager>
      </otherManagersInfo>
      <provideInfoForInstruction>Y</provideInfoForInstruction>
      <additionalInformation>The report on Form 13F for the period ended September 30, 2026 for BCLS II Investco, LP (the "Fund") is being filed by Bain Capital Life Sciences Investors, LLC, which is the manager of Bain Capital Life Sciences Investors II, LLC, which is the general partner of Bain Capital Life Sciences Fund II, L.P., which is the manager of BCLS II Investco (GP), LLC, which is the general partner of the Fund.</additionalInformation>
    </coverPage>
    <signatureBlock>
      <name>Adam Koppel</name>
      <title>Partner of Bain Capital Life Sciences Investors, LLC</title>
      <phone>617-516-2000</phone>
      <signature>/s/ Adam Koppel</signature>
      <city>Boston </city>
      <stateOrCountry>MA</stateOrCountry>
      <signatureDate>11-16-2026</signatureDate>
    </signatureBlock>
  </formData>
</edgarSubmission>
